Back to search
Refractory Epilepsy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Epilepsy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Epilepsy trials you may qualify forDravet Syndrome (DS) is a severe neurodevelopmental disease, which is predominantly caused by mutations of SCN1A, the gene coding for Nav1.1 voltage-gated sodiu…
The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.
Patients with drug-refractory epilepsy sometimes need to be implanted with intracerebral electrodes in order to identify their seizure onset zone. During this p…
The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well capture…
The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well…
The aim of the MicroEPI study is to know whether it is possible to use safely a medical device (a micro-electrode) that allows recording the activity of neurons…
This project aims to conduct a pilot study based on the targeting of the epileptogenic zone previously localized very precisely by stereoelectroencephalography…
Full Title: Fenfluramine for the treatment of refractory Epilepsy in Adult Dravet patients Short Title: Fenfluramine for Adult Dravet patients Clinical Phase:…
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy